Literature DB >> 32736327

EEG findings in COVID-19 related encephalopathy.

Elena Pasini1, Francesca Bisulli2, Lilia Volpi3, Irene Minardi3, Maria Tappatà3, Lorenzo Muccioli4, Umberto Pensato4, Patrizia Riguzzi3, Paolo Tinuper2, Roberto Michelucci3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32736327      PMCID: PMC7367805          DOI: 10.1016/j.clinph.2020.07.003

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


× No keyword cloud information.
Vellieux et al recently reported two coronavirus disease 2019 (COVID-19) patients showing a unique EEG pattern, i.e., non-reactive bifrontal monomorphic diphasic periodic delta waves, and suggested that this pattern could be typical of COVID-19 brain dysfunction (Vellieux et al., 2020). Here we report the EEG findings in 15 patients with suspected COVID-19 related encephalopathy, stemming from a population of 873 patients admitted to our hospital in a 3 months period (from March 1 to May 31, 2020) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In detail, these were 6 males and 9 females, with a mean age of 64.6 years (range: 47–79 years). The mean delay between the COVID-19 infection and the onset of neurological symptoms prompting the execution of the EEG was 8 days. The main neurological symptoms included confusion (11 patients), aphasia (1 patient), and impairment of consciousness (4 patients). Out of the 4 patients with impairment of consciousness, two had post-anoxic coma after respiratory distress, one multi-organ failure, and one critical illness myopathy/neuropathy with brainstem involvement. Comorbid conditions likely to influence the EEG tracings were present in 5 cases and included cognitive decline (2 patients), previous limbic encephalitis (1 patient), multi-organ failure (1 patient) and frontal metastasis (1 patient). EEG recordings were performed with a Nihon Kohden Neurofax EEG 1200 K instrument using 18 scalp electrodes positioned according to the standard 10–20 international system. All the records had a EKG. The O2 saturation was also checked at the time of the EEG and was >93% in all cases. Patients were stimulated by verbal commands, opening of the eyes, and when arousals were not evoked, noxious stimuli like sternal rub and toe compression were applied. Arousals were defined according to standard criteria as abrupt shift in frequency of background activity, lasting for 3 s or more that may have included theta, alpha and/or frequencies >16 Hz but no spindles. All EEG recordings were analyzed by two experienced neurologists (RM, EP) trained in EEG interpretation. The EEGs were abnormal in all cases. In the two patients with post-anoxic coma, the EEG showed in one case severely suppressed activity on the first day after return of spontaneous circulation (ROSC) and in the second case discontinued activity compatible with post-anoxic status epilepticus on the third day after ROSC. In the remaining 13 patients the EEG abnormalities included slowing of the background activity ranging from 4 to 8 Hz (with theta prevalence in 5 cases and intrusions of theta/delta activity in 4 cases), focal theta or delta waves predominantly over the frontal or central regions (3 patients) and frontal intermittent rhythmic delta activity (FIRDA) (1 patient) (Fig. 1 A). Reactivity to external stimuli and eye opening/closure was absent in 10 cases (Fig. 1B). The severity of slowing of the background activity varied widely among patients and correlated with the clinical picture. No epileptiform abnormalities or triphasic waves were observed. Repeat EEGs were avaiable in 3 patients and showed marked improvement of posterior activity, in accord with the improvement of neurological symptoms.
Fig. 1

EEG of two COVID-19 positive patients, both clinically alert and conscious but confused. (A) EEG of the first patient shows a disorganized alpha-theta background activity with frontal intermittent rhythmic delta activity (FIRDA). (B) EEG of the second patient, who in addition showed non-fluent aphasia, is characterised by monomorphic diffuse alpha-like rhythm without reactivity after eyes closure.

EEG of two COVID-19 positive patients, both clinically alert and conscious but confused. (A) EEG of the first patient shows a disorganized alpha-theta background activity with frontal intermittent rhythmic delta activity (FIRDA). (B) EEG of the second patient, who in addition showed non-fluent aphasia, is characterised by monomorphic diffuse alpha-like rhythm without reactivity after eyes closure. CT scans (8 cases), MRI (6 cases) and spinal tap (5 cases) were also performed. These tests were normal in all cases except for mild MRI T2 hyperintensity in the white matter in two cases and slight elevation of cerebrospinal fluid (CSF) protein in one patient. SARS-CoV-2 was not detected in the CSF in any case. EEG findings in SARS-CoV-2 infection have been rarely reported and largely considered non-specific (Flamand et al., 2020, Vellieux et al., 2020). Indeed, EEG in acute encephalopathies may reveal different degrees of background slowing, with or without triphasic waves and FIRDA and these patterns are believed to reflect an underlying structural or metabolic disorder; however, there is limited evidence linking specific EEG abnormalities with plausible causative factors. Absent EEG reactivity with bifrontal monomorphic periodic delta waves was reported by Vellieux et al., who suggested that this pattern could be specific of COVID-19 related encephalopathy (Vellieux et al., 2020). Accordingly, in our series, apart from the 2 post-hypoxic patients, the EEG characteristics were quite homogeneous, though non-specific, and included non-reactive, slow, monomorphic and disorganized background activity. We may hypothesize that, while the slowing of background activity may suggest a diffuse cortical involvement, the lack of reactivity to external stimuli along with the monomorphic pattern of the EEG and occasional frontal delta waves may denote a concomitant subcortical or brainstem dysfunction (Sutter et al., 2013). The pathophysiology of these changes remains elusive, however, and a multifactorial origin has been postulated although a metabolic/hypoxic mechanism seems unlikely on the basis of our EEG findings (Flamand et al., 2020). Notwithstanding, the EEG remains the most sensitive tool to disclose the existence of a COVID-19 related encephalopathy, taking into account the limited usefulness of other diagnostic tests (Paterson et al., 2020). In our experience the EEG was performed in only a minority of patients with SARS-CoV-2 infection, particularly in those showing overt signs of CNS involvement. It may be argued that a more widespread use of the EEG would have disclosed a higher rate of neurological complications. In conclusion, our observations confirm the high sensitivity of the EEG and its localization value in encephalopathies, contributing to unravel also mild cases of COVID-19 related brain dysfunction. In detail, we have shown that COVID-19 related encephalopathy may be associated with a rather homogeneous EEG pattern consisting of a diffuse slowing of the background activity and loss of reactivity to external stimuli. Whether or not these EEG findings may be specific for COVID-19 related encephalopathy is unknown and deserves further investigation.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors contributions

EP and RM analyzed EEG and wrote the manuscript. FB and PT suggested and revised the manuscript. LV, IM, MT, LM, UP, PR gave their clinician expertise.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  15 in total

1.  EEG Abnormalities and Their Radiographic Correlates in a COVID-19 Inpatient Cohort.

Authors:  Sean T Hwang; Ahmad A Ballout; Anup N Sonti; Amitha Kapyur; Claudia Kirsch; Neeraj Singh; Noah Markowitz; Tung Ming Leung; Derek J Chong; Richard Temes; Steven V Pacia; Ruben I Kuzniecky; Souhel Najjar
Journal:  Neurol Clin Pract       Date:  2022-02

2.  Non-Invasive Multimodal Neuromonitoring in Non-Critically Ill Hospitalized Adult Patients With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Denise Battaglini; Lavienraj Premraj; Samuel Huth; Jonathon Fanning; Glenn Whitman; Rakesh C Arora; Judith Bellapart; Diego Bastos Porto; Fabio Silvio Taccone; Jacky Y Suen; Gianluigi Li Bassi; John F Fraser; Rafael Badenes; Sung-Min Cho; Chiara Robba
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.086

3.  COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment.

Authors:  Lorenzo Muccioli; Umberto Pensato; Ilaria Cani; Luca Guerra; Federica Provini; Giorgio Bordin; Luca Albini Riccioli; Raffaele Lodi; Paolo Tinuper; Francesca Bisulli
Journal:  J Neuroimmunol       Date:  2020-09-24       Impact factor: 3.478

4.  Isolated Encephalopathy Without Severe Disease in a COVID-19 Patient: Case Presentation and Workup Strategies.

Authors:  Lindsay S McAlpine; Mary Barden; Adeel S Zubair; Sirisha Sanamandra
Journal:  Cureus       Date:  2021-02-11

5.  Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.

Authors:  Umberto Pensato; Lorenzo Muccioli; Ilaria Cani; Damir Janigro; Pier Luigi Zinzani; Maria Guarino; Pietro Cortelli; Francesca Bisulli
Journal:  Ann Clin Transl Neurol       Date:  2021-03-29       Impact factor: 4.511

Review 6.  Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

Authors:  Andrea Stracciari; Gabriella Bottini; Maria Guarino; Eugenio Magni; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2021-04-12       Impact factor: 3.307

7.  Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19.

Authors:  Virginie Lambrecq; Aurélie Hanin; Esteban Munoz-Musat; Lydia Chougar; Salimata Gassama; Cécile Delorme; Louis Cousyn; Alaina Borden; Maria Damiano; Valerio Frazzini; Gilles Huberfeld; Frank Landgraf; Vi-Huong Nguyen-Michel; Phintip Pichit; Aude Sangare; Mario Chavez; Capucine Morélot-Panzini; Elise Morawiec; Mathieu Raux; Charles-Edouard Luyt; Pierre Rufat; Damien Galanaud; Jean-Christophe Corvol; Catherine Lubetzki; Benjamin Rohaut; Sophie Demeret; Nadya Pyatigorskaya; Lionel Naccache; Vincent Navarro
Journal:  JAMA Netw Open       Date:  2021-03-01

8.  COVID-19, de novo seizures, and epilepsy: a systematic review.

Authors:  Ali A Asadi-Pooya; Leila Simani; Mina Shahisavandi; Zohreh Barzegar
Journal:  Neurol Sci       Date:  2020-11-25       Impact factor: 3.830

Review 9.  Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China.

Authors:  Haojun Yang; Yunfang Chi; Zhuohui Chen; Yishu Fan; Haiyue Wu; Xinhang Hu; Tong Wu; Bo Xiao; Mengqi Zhang
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

10.  Retrospective Analysis of EEG in Patients With COVID-19: EEG Recording in Acute and Follow-up Phases.

Authors:  Isabel Sáez-Landete; Adriana Gómez-Domínguez; Beatriz Estrella-León; Alba Díaz-Cid; Olga Fedirchyk; Marta Escribano-Muñoz; Antonio Pedrera-Mazarro; Guillermo Martín-Palomeque; Guillermo Garcia-Ribas; Fernando Rodríguez-Jorge; Gloria Santos-Pérez; Daniel Lourido-García; Ignacio Regidor-BaillyBailliere
Journal:  Clin EEG Neurosci       Date:  2021-07-28       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.